Asthma research in Europe: a transformative agenda for innovation and competitiveness
Eur Respir J
.
2017 May 1;49(5):1602294.
doi: 10.1183/13993003.02294-2016.
Print 2017 May.
Authors
Nikolaos G Papadopoulos
1
2
,
Aggeliki Androutsopoulou
3
,
Cezmi Akdis
4
,
Sven-Erik Dahlén
5
,
Ratko Djukanovic
6
,
Jessica Edwards
7
,
Luis Garcia-Marcos
8
,
Sebastian L Johnston
9
,
Maciek Kupczyk
10
,
Thomas R Martin
11
,
David Myles
12
,
Susanna Palkonen
13
,
Pippa Powell
14
,
John Riley
12
,
Samantha Walker
7
Affiliations
1
National Kapodistrian University of Athens, Athens, Greece ngpallergy@gmail.com.
2
University of Manchester, Manchester, UK.
3
National Kapodistrian University of Athens, Athens, Greece.
4
Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich Faculty of Medicine, Davos, Switzerland.
5
IMM Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
6
NIHR Southampton Respiratory Biomedical Research Unit, University of Southampton, Southampton, UK.
7
Asthma UK, London, UK.
8
Paediatric Pulmonology and Allergy, "Virgen de la Arrixaca" University Children's Hospital, University of Murcia, Murcia, Spain.
9
National Heart and Lung Institute, Imperial College London, London, UK.
10
Medical University of Łódź, Łódź, Poland.
11
Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, USA.
12
GlaxoSmithKline, Stevenage, UK.
13
European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.
14
European Lung Foundation (ELF), Sheffield, UK.
PMID:
28461296
DOI:
10.1183/13993003.02294-2016
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
MeSH terms
Asthma / epidemiology*
Biomedical Research / trends*
Europe / epidemiology
Humans
Grants and funding
G1000758/MRC_/Medical Research Council/United Kingdom